Login to Your Account



Relatively Resistance Resistant

Preclinically, Saridegib Shows Promise for Medulloblastoma

By Anette Breindl
Science Editor

Monday, May 7, 2012

The Sonic Hedgehog pathway is a critical developmental pathway that is reactivated in a number of cancers. Results with targeting the pathway to treat cancers have been mixed, as drug development is wont to be. But the successes have been enough to keep trying.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription